{"entities": {"mentions": [{"start": 0, "end": 14, "username": "KeishaBottoms", "id": "305818748"}], "hashtags": [{"start": 281, "end": 289, "tag": "COVID19"}]}, "created_at": "2020-07-08T17:02:25.000Z", "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}, {"domain": {"id": "29", "name": "Events [Entity Service]", "description": "Entity Service related Events domain"}, "entity": {"id": "1219057585707315201", "name": "COVID-19: Latest news updates from around the world", "description": "This page is a timeline of Tweets with the latest information and updates on COVID-19 from experts, journalists, health authorities and other trusted sources from around the world. For more on COVID-19, visit: twitter.com/explore/tabs/covid-19"}}], "possibly_sensitive": false, "public_metrics": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}, "author_id": "930814884", "reply_settings": "everyone", "source": "Twitter for iPhone", "text": "@KeishaBottoms The National Gaurd is not the answer. The problem is the equipment and reagents needed for performing the tests. These are in short supply and being rationed by manufacturers so they are distributed to labs fairly. The DPA could\u2019ve helped if implemented months ago. #COVID19", "in_reply_to_user_id": "305818748", "id": "1280910118285201411", "lang": "en", "referenced_tweets": [{"type": "replied_to", "id": "1280824621214896129"}], "conversation_id": "1280824621214896129"}